Year |
Citation |
Score |
2023 |
Tempio A, Boulksibat A, Bardoni B, Delhaye S. Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments. Frontiers in Neuroscience. 17: 1171895. PMID 37188005 DOI: 10.3389/fnins.2023.1171895 |
0.435 |
|
2022 |
Kieffer F, Hilal F, Gay AS, Debayle D, Pronot M, Poupon G, Lacagne I, Bardoni B, Martin S, Gwizdek C. Combining affinity purification and mass spectrometry to define the network of the nuclear proteins interacting with the N-terminal region of FMRP. Frontiers in Molecular Biosciences. 9: 954087. PMID 36237573 DOI: 10.3389/fmolb.2022.954087 |
0.439 |
|
2022 |
Schiavi S, Carbone E, Melancia F, di Masi A, Jarjat M, Brau F, Cardarelli S, Giorgi M, Bardoni B, Trezza V. Phosphodiesterase 2A inhibition corrects the aberrant behavioral traits observed in genetic and environmental preclinical models of Autism Spectrum Disorder. Translational Psychiatry. 12: 119. PMID 35338117 DOI: 10.1038/s41398-022-01885-2 |
0.505 |
|
2021 |
Bach S, Shovlin S, Moriarty M, Bardoni B, Tropea D. Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions. Frontiers in Cellular Neuroscience. 15: 764761. PMID 34867203 DOI: 10.3389/fncel.2021.764761 |
0.487 |
|
2021 |
Prieto M, Folci A, Poupon G, Schiavi S, Buzzelli V, Pronot M, François U, Pousinha P, Lattuada N, Abelanet S, Castagnola S, Chafai M, Khayachi A, Gwizdek C, Brau F, ... ... Bardoni B, et al. Missense mutation of Fmr1 results in impaired AMPAR-mediated plasticity and socio-cognitive deficits in mice. Nature Communications. 12: 1557. PMID 33692361 DOI: 10.1038/s41467-021-21820-1 |
0.58 |
|
2019 |
Drozd M, Delhaye S, Maurin T, Castagnola S, Grossi M, Brau F, Jarjat M, Willemsen R, Capovilla M, Hukema RK, Lalli E, Bardoni B. Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTAS. Molecular Therapy. Nucleic Acids. 18: 546-553. PMID 31671347 DOI: 10.1016/j.omtn.2019.09.018 |
0.383 |
|
2018 |
Maurin T, Bardoni B. Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer. Frontiers in Molecular Biosciences. 5: 113. PMID 30619879 DOI: 10.3389/fmolb.2018.00113 |
0.377 |
|
2018 |
Maurin T, Melancia F, Jarjat M, Castro L, Costa L, Delhaye S, Khayachi A, Castagnola S, Mota E, Di Giorgio A, Servadio M, Drozd M, Poupon G, Schiavi S, Sardone L, ... ... Bardoni B, et al. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome. Cerebral Cortex (New York, N.Y. : 1991). PMID 30137253 DOI: 10.1093/Cercor/Bhy192 |
0.612 |
|
2018 |
Drozd M, Bardoni B, Capovilla M. Modeling Fragile X Syndrome in . Frontiers in Molecular Neuroscience. 11: 124. PMID 29713264 DOI: 10.3389/fnmol.2018.00124 |
0.409 |
|
2018 |
Maurin T, Lebrigand K, Castagnola S, Paquet A, Jarjat M, Popa A, Grossi M, Rage F, Bardoni B. HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein. Nucleic Acids Research. 46: 6344-6355. PMID 29668986 DOI: 10.1093/nar/gky267 |
0.408 |
|
2018 |
Khayachi A, Gwizdek C, Poupon G, Alcor D, Chafai M, Cassé F, Maurin T, Prieto M, Folci A, De Graeve F, Castagnola S, Gautier R, Schorova L, Loriol C, Pronot M, ... ... Bardoni B, et al. Sumoylation regulates FMRP-mediated dendritic spine elimination and maturation. Nature Communications. 9: 757. PMID 29472612 DOI: 10.1038/s41467-018-03222-y |
0.478 |
|
2017 |
Castagnola S, Bardoni B, Maurin T. The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality? Frontiers in Synaptic Neuroscience. 9: 15. PMID 29163124 DOI: 10.3389/fnsyn.2017.00015 |
0.409 |
|
2017 |
Bardoni B, Capovilla M, Lalli E. Modeling Fragile X syndrome in neurogenesis: An unexpected phenotype and a novel tool for future therapies. Neurogenesis (Austin, Tex.). 4: e1270384. PMID 28203608 DOI: 10.1080/23262133.2016.1270384 |
0.406 |
|
2017 |
Abekhoukh S, Sahin HB, Grossi M, Zongaro S, Maurin T, Madrigal I, Kazue-Sugioka D, Raas-Rothschild A, Doulazmi M, Carrera P, Stachon A, Scherer S, Nascimento MR, Trembleau A, Arroyo I, ... ... Bardoni B, et al. New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes. Disease Models & Mechanisms. PMID 28183735 DOI: 10.1242/Dmm.025809 |
0.45 |
|
2016 |
Khalfallah O, Jarjat M, Davidovic L, Nottet N, Cestèle S, Mantegazza M, Bardoni B. Depletion of the fragile X mental retardation protein in embryonic stem cells alters the kinetics of neurogenesis. Stem Cells (Dayton, Ohio). PMID 27664080 DOI: 10.1002/Stem.2505 |
0.458 |
|
2016 |
Tabet R, Moutin E, Becker JA, Heintz D, Fouillen L, Flatter E, Krężel W, Alunni V, Koebel P, Dembélé D, Tassone F, Bardoni B, Mandel JL, Vitale N, Muller D, et al. Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons. Proceedings of the National Academy of Sciences of the United States of America. PMID 27233938 DOI: 10.1073/Pnas.1522631113 |
0.612 |
|
2015 |
Vicario A, Colliva A, Ratti A, Davidovic L, Baj G, Gricman Ł, Colombrita C, Pallavicini A, Jones KR, Bardoni B, Tongiorgi E. Dendritic targeting of short and long 3' UTR BDNF mRNA is regulated by BDNF or NT-3 and distinct sets of RNA-binding proteins. Frontiers in Molecular Neuroscience. 8: 62. PMID 26578876 DOI: 10.3389/Fnmol.2015.00062 |
0.349 |
|
2015 |
Maurin T, Melko M, Abekhoukh S, Khalfallah O, Davidovic L, Jarjat M, D'Antoni S, Catania MV, Moine H, Bechara E, Bardoni B. The FMRP/GRK4 mRNA interaction uncovers a new mode of binding of the Fragile X mental retardation protein in cerebellum. Nucleic Acids Research. 43: 8540-50. PMID 26250109 DOI: 10.1093/Nar/Gkv801 |
0.401 |
|
2014 |
Matic K, Eninger T, Bardoni B, Davidovic L, Macek B. Quantitative phosphoproteomics of murine Fmr1-KO cell lines provides new insights into FMRP-dependent signal transduction mechanisms. Journal of Proteome Research. 13: 4388-97. PMID 25168779 DOI: 10.1021/Pr5006372 |
0.425 |
|
2014 |
Abekhoukh S, Bardoni B. CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome. Frontiers in Cellular Neuroscience. 8: 81. PMID 24733999 DOI: 10.3389/fncel.2014.00081 |
0.482 |
|
2014 |
Maurin T, Zongaro S, Bardoni B. Fragile X Syndrome: from molecular pathology to therapy. Neuroscience and Biobehavioral Reviews. 46: 242-55. PMID 24462888 DOI: 10.1016/j.neubiorev.2014.01.006 |
0.466 |
|
2013 |
Melko M, Nguyen LS, Shaw M, Jolly L, Bardoni B, Gecz J. Loss of FMR2 further emphasizes the link between deregulation of immediate early response genes FOS and JUN and intellectual disability Human Molecular Genetics. 22: 2984-2991. PMID 23562910 DOI: 10.1093/hmg/ddt155 |
0.313 |
|
2013 |
Davidovic L, Durand N, Khalfallah O, Tabet R, Barbry P, Mari B, Sacconi S, Moine H, Bardoni B. A novel role for the RNA-binding protein FXR1P in myoblasts cell-cycle progression by modulating p21/Cdkn1a/Cip1/Waf1 mRNA stability. Plos Genetics. 9: e1003367. PMID 23555284 DOI: 10.1371/Journal.Pgen.1003367 |
0.364 |
|
2012 |
Bardoni B, Abekhoukh S, Zongaro S, Melko M. Intellectual disabilities, neuronal posttranscriptional RNA metabolism, and RNA-binding proteins: three actors for a complex scenario. Progress in Brain Research. 197: 29-51. PMID 22541287 DOI: 10.1016/B978-0-444-54299-1.00003-0 |
0.411 |
|
2011 |
Davidovic L, Navratil V, Bonaccorso CM, Catania MV, Bardoni B, Dumas ME. A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model. Genome Research. 21: 2190-202. PMID 21900387 DOI: 10.1101/Gr.116764.110 |
0.341 |
|
2010 |
Melko M, Bardoni B. The role of G-quadruplex in RNA metabolism: involvement of FMRP and FMR2P. Biochimie. 92: 919-26. PMID 20570707 DOI: 10.1016/j.biochi.2010.05.018 |
0.415 |
|
2009 |
Bechara EG, Didiot MC, Melko M, Davidovic L, Bensaid M, Martin P, Castets M, Pognonec P, Khandjian EW, Moine H, Bardoni B. A novel function for fragile X mental retardation protein in translational activation. Plos Biology. 7: e16. PMID 19166269 DOI: 10.1371/Journal.Pbio.1000016 |
0.437 |
|
2009 |
Bensaid M, Melko M, Bechara EG, Davidovic L, Berretta A, Catania MV, Gecz J, Lalli E, Bardoni B. FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure. Nucleic Acids Research. 37: 1269-79. PMID 19136466 DOI: 10.1093/Nar/Gkn1058 |
0.385 |
|
2007 |
Davidovic L, Jaglin XH, Lepagnol-Bestel AM, Tremblay S, Simonneau M, Bardoni B, Khandjian EW. The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules. Human Molecular Genetics. 16: 3047-58. PMID 17881655 DOI: 10.1093/Hmg/Ddm263 |
0.457 |
|
2007 |
Bechara E, Davidovic L, Melko M, Bensaid M, Tremblay S, Grosgeorge J, Khandjian EW, Lalli E, Bardoni B. Fragile X related protein 1 isoforms differentially modulate the affinity of fragile X mental retardation protein for G-quartet RNA structure. Nucleic Acids Research. 35: 299-306. PMID 17170008 DOI: 10.1093/Nar/Gkl1021 |
0.438 |
|
2006 |
Bardoni B, Davidovic L, Bensaid M, Khandjian EW. The fragile X syndrome: exploring its molecular basis and seeking a treatment. Expert Reviews in Molecular Medicine. 8: 1-16. PMID 16626504 DOI: 10.1017/S1462399406010751 |
0.479 |
|
2006 |
Davidovic L, Bechara E, Gravel M, Jaglin XH, Tremblay S, Sik A, Bardoni B, Khandjian EW. The nuclear microspherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons. Human Molecular Genetics. 15: 1525-38. PMID 16571602 DOI: 10.1093/Hmg/Ddl074 |
0.502 |
|
2006 |
Ramos A, Hollingworth D, Adinolfi S, Castets M, Kelly G, Frenkiel TA, Bardoni B, Pastore A. The structure of the N-terminal domain of the fragile X mental retardation protein: A platform for protein-protein interaction Structure. 14: 21-31. PMID 16407062 DOI: 10.1016/j.str.2005.09.018 |
0.358 |
|
2005 |
Castets M, Schaeffer C, Bechara E, Schenck A, Khandjian EW, Luche S, Moine H, Rabilloud T, Mandel JL, Bardoni B. FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts. Human Molecular Genetics. 14: 835-44. PMID 15703194 DOI: 10.1093/Hmg/Ddi077 |
0.609 |
|
2004 |
Schenck A, Qurashi A, Carrera P, Bardoni B, Diebold C, Schejter E, Mandel JL, Giangrande A. WAVE/SCAR, a multifunctional complex coordinating different aspects of neuronal connectivity. Developmental Biology. 274: 260-70. PMID 15385157 DOI: 10.1016/J.Ydbio.2004.07.009 |
0.525 |
|
2004 |
Khandjian EW, Huot ME, Tremblay S, Davidovic L, Mazroui R, Bardoni B. Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles. Proceedings of the National Academy of Sciences of the United States of America. 101: 13357-62. PMID 15329415 DOI: 10.1073/Pnas.0405398101 |
0.499 |
|
2003 |
Bardoni B, Willemsen R, Weiler IJ, Schenck A, Severijnen LA, Hindelang C, Lalli E, Mandel JL. NUFIP1 (nuclear FMRP interacting protein 1) is a nucleocytoplasmic shuttling protein associated with active synaptoneurosomes. Experimental Cell Research. 289: 95-107. PMID 12941608 DOI: 10.1016/S0014-4827(03)00222-2 |
0.596 |
|
2003 |
Bardoni B, Castets M, Huot ME, Schenk A, Adinolfi S, Corbin F, Pastore A, Khandjian EW, Mandel JL. 82-FIP, a novel FMRP (Fragile X Mental Retardation Protein) interacting protein, shows a cell cycle-dependent intracellular localization Human Molecular Genetics. 12: 1689-1698. PMID 12837692 DOI: 10.1093/Hmg/Ddg181 |
0.565 |
|
2003 |
Schenck A, Bardoni B, Langmann C, Harden N, Mandel JL, Giangrande A. CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron. 38: 887-98. PMID 12818175 DOI: 10.1016/S0896-6273(03)00354-4 |
0.616 |
|
2002 |
Schenck A, Van de Bor V, Bardoni B, Giangrande A. Novel features of dFMR1, the Drosophila orthologue of the fragile X mental retardation protein. Neurobiology of Disease. 11: 53-63. PMID 12460546 DOI: 10.1006/Nbdi.2002.0510 |
0.324 |
|
2002 |
Bardoni B, Mandel JL. Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. Current Opinion in Genetics & Development. 12: 284-93. PMID 12076671 DOI: 10.1016/S0959-437X(02)00300-3 |
0.622 |
|
Show low-probability matches. |